Pine Valley Investments’s VanEck Biotech ETF BBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$396K Hold
1,950
0.02% 438
2026
Q1
$367K Hold
1,950
0.02% 426
2025
Q4
$369K Sell
1,950
-200
-9% -$37K 0.02% 411
2025
Q3
$356K Hold
2,150
0.02% 410
2025
Q2
$330K Hold
2,150
0.02% 411
2025
Q1
$338K Hold
2,150
0.02% 395
2024
Q4
$337K Sell
2,150
-20
-0.9% -$3.37K 0.02% 403
2024
Q3
$385K Hold
2,170
0.02% 365
2024
Q2
$365K Buy
2,170
+20
+0.9% +$3.27K 0.02% 353
2024
Q1
$358K Hold
2,150
0.02% 363
2023
Q4
$355K Buy
2,150
+250
+13% +$38.5K 0.03% 354
2023
Q3
$296K Sell
1,900
-150
-7% -$24K 0.03% 366
2023
Q2
$320K Buy
+2,050
New +$327K 0.03% 311

Other funds holding BBH

Pine Valley Investments's BBH Position: Q2 2026 in Review

Pine Valley Investments held its VanEck Biotech ETF (BBH) position steady in Q2 2026 at 1,950 shares worth $396K. The position accounts for 0.02% of the portfolio, ranked #438.

Pine Valley Investments first reported a position in BBH in Q2 2023 and has held it in 13 quarters since. 46 funds tracked by Wall St. Rank hold BBH as of Q2 2026.

  • Pine Valley Investments held 1,950 shares of VanEck Biotech ETF worth $396K as of Q2 2026.
  • Pine Valley Investments left its VanEck Biotech ETF share count unchanged in Q2 2026.
  • VanEck Biotech ETF made up 0.02% of Pine Valley Investments's portfolio in Q2 2026, its #438 holding.
  • Pine Valley Investments first reported a position in VanEck Biotech ETF in Q2 2023 and has held it in 13 quarters since.
  • 46 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q2 2026.

Based on Pine Valley Investments's 13F filing for Q2 2026, filed 24 Jul 2026.